| 12th Annual Parallel Trade
|Holiday Inn Kensington Forum, London, UK
06/02/2018 - 07/02/2018
Click here for the event website.
| Contact Email:
| Contact Tel:
||+44 (0) 207 827 6012
SMi Group is proud to announce the return of Europes only Parallel Trade conference. Back for the 12th year, Parallel Trade returns to London on 6th-7th February 2018.
Over the years, the European Single market has allowed for pharmaceuticals to be imported and exported freely between member states without the permission of the manufacturers.
However, with the arrival of Brexit and guidelines to immanently enforce the Falsified Medicines Directive (FMD) by 2019, the market for pharmaceutical parallel trade is changing.
Join us as we discuss the latest changes to regulation, their implementation and major court cases in intellectual property influencing distribution practices. We will also be exploring the safety of patients in relation to the surge in pharmaceutical E-commerce and ways in which currency fluctuations are likely to disrupt the flow of drugs to certain countries in the EU and beyond.
With huge interest from leaders in the field, we have worked closely with an expert panel of speakers to present an agenda that is shaping up to be the best Parallel Trade event. This year's event will continue to lead with its unrivalled panel of experts bringing you the most insightful presentations from our confirmed Industry-leading speakers:
Antonio Mendonca Alves, CEO, Md Pharma Sa
Christopher Stothers, Partner, Arnold And Porter Kaye Scholer Llp
Darragh O'loughlin, Secretary General, Irish Pharmacy Union
Eric Noehrenberg, President, Noehrenberg International Policy Consulting
Fabrizio Gianfrate, Professor of Health Economics, University of Ferrara
Farasat Bokhari, Senior Lecturer in Economics, Uea, University of East Anglia
Felipe Florez-Arango, Head of Finance, Europe, Shire
Frank Weissenfeldt, Senior Manager, Supplier Relations, Quintilesims
Heinz Kobelt, Director European Affairs, European Association of Euro-Pharmaceutical Companies
Ian Walker, Chairman, Epilepsy Action
Janice Haigh, VP Pricing & Market Access, Parexel
John Jolley, Managing Director, Pharmaconsult Global Ltd
Mikas Rimantas, Business Development Director, Lexano
Werner Berg, Partner, Baker & Mckenzie
Parallel Trade will address short term versus long term concerns of pharmaceutical manufacturers, regulators, parallel traders and patient associations.
The 2018 Parallel Trade conference will cover the important issues of:
Maintaining the integrity of the supply chain
Addressing recent developments concerning intellectual property and regulatory law
Forecasting currency fluctuations across the single market and the affect this might have on drug shortages, prices and patient accessibility
Exploring how Brexit will impact pharmaceutical trade and
market access in Europe
Providing an insight into current anti-trust investigations from industry leaders and the consequences this could have on pharmaceutical parallel trade